Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;89:195-197

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Libby, P.
Right arrow Articles by Schönbeck, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Libby, P.
Right arrow Articles by Schönbeck, U.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OXYGEN
(Circulation Research. 2001;89:195.)
© 2001 American Heart Association, Inc.


Editorial

Drilling for Oxygen

Angiogenesis Involves Proteolysis of the Extracellular Matrix

Peter Libby, Uwe Schönbeck

From the Leducq Center for Cardiovascular Research, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.

Correspondence to Peter Libby, MD, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Woman’s Hospital, 221 Longwood Ave, LMRC 307, Boston, MA 02115. E-mail plibby@rics.bwh.harvard.edu


Key Words: extracellular matrix • matrix metalloproteinases • endothelium • inflammation • angiogenesis

All acknowledge the importance of endothelial migration and proliferation in angiogenesis. However, the sprouting of extensions of established vascular channels in most tissues requires much more. The extracellular space does not consist of a vacuum, permitting free spread of endothelial sprouts during angiogenesis. Rather, a complex and often dense extracellular matrix invests the parenchymal cells and microvascular channels of most organs. The endothelial cells must penetrate this extracellular matrix to make a new vessel (Figure 1A). Immediately surrounding the endothelial cells, a basement membrane of type IV collagen, laminin, fibronectin, and many other matrix macromolecules presents the first obstacle to neovascular sprout formation (Figure 1B). That barrier breached, the nascent microvessel must then burrow through collagen fibrils, elastin, microfibrillar proteins, proteoglycans, and other constituents of the surrounding extracellular matrix (Figure 1C). How do the endothelial cells drill their way through these layered impediments to form a new vessel?


Figure Removed (Available Only in the Full Text)
View larger version (52K):
[in this window]
[in a new window]
 
Figure 1. Formation of neovessels. A, To form new vessels, the endothelial cell layer (typically in a venule) must break down the subjacent basement membrane, composed of a complex mixture of many extracellular matrix components including type IV collagen, laminin, and fibronectin. B, Local action of proteolytic enzymes such as type IV collagenase (MMP-2) activated by MT1-MMP (MMP-14) aids dissolution of a patch of basement membrane. C, Other proteinases, including the MMPs that degrade fibrillar collagen (eg, MMP-1 and MMP-13) or proteoglycan core proteins (eg, MMP-9), assist the subsequent step in which endothelial cells force a . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
CirculationHome page
J. Yoshioka and R. T. Lee
Vascularization as a Potential Enemy in Valvular Heart Disease
Circulation, October 21, 2008; 118(17): 1694 - 1694.
[Full Text] [PDF]


Home page
RadiologyHome page
X. Montet, J.-L. Figueiredo, H. Alencar, V. Ntziachristos, U. Mahmood, and R. Weissleder
Tomographic Fluorescence Imaging of Tumor Vascular Volume in Mice
Radiology, March 1, 2007; 242(3): 751 - 758.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Herrmann, L. O. Lerman, D. Mukhopadhyay, C. Napoli, and A. Lerman
Angiogenesis in Atherogenesis
Arterioscler Thromb Vasc Biol, September 1, 2006; 26(9): 1948 - 1957.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Liu, G. K. Sukhova, J.-S. Sun, W.-H. Xu, P. Libby, and G.-P. Shi
Lysosomal Cysteine Proteases in Atherosclerosis
Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1359 - 1366.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Schonbeck and P. Libby
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?
Circulation, June 1, 2004; 109(21_suppl_1): II-18 - II-26.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
M. ANGHELINA, A. SCHMEISSER, P. KRISHNAN, L. MOLDOVAN, R.H. STRASSER, and N.I. MOLDOVAN
Migration of Monocytes/Macrophages In Vitro and In Vivo Is Accompanied by MMP12-dependent Tunnel Formation and by Neovascularization
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 209 - 216.
[Abstract] [PDF]


Home page
CirculationHome page
M. L. Lindsey, J. Gannon, M. Aikawa, F. J. Schoen, E. Rabkin, L. Lopresti-Morrow, J. Crawford, S. Black, P. Libby, P. G. Mitchell, et al.
Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction
Circulation, February 12, 2002; 105(6): 753 - 758.
[Abstract] [Full Text] [PDF]